Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00217646
Status:
COMPLETED
Last Update Posted:
2015-04-28
First Post:
2005-09-20
Brief Title:
Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia Myelodysplastic Syndromes or Blastic Phase Chronic Myelogenous Leukemia
Sponsor:
Organization:
National Cancer Institute NCI